Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma

R. M. Gemmill, M. Zhou, L. Costa, C. Korch, R. M. Bukowski, H. A. Drabkin

Research output: Contribution to journalArticle

46 Scopus citations

Fingerprint Dive into the research topics of 'Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences